TABLE 4.
Average Marginal Effects on Physical Exams for Breast Cancer Survivors After Primary Therapy† From 2-part Model
| Cohort 3a | Cohort 3b | |||
|---|---|---|---|---|
|
|
|
|||
| Marginal Effect on Receipt of 2 Physical Exams‡ |
95% CI | Marginal Effect on No. Physical Exams‡ |
95% CI | |
| Months in medical home | 0.001 | −0.007, 0.008 | −0.066 | −0.197, 0.065 |
| Clinical characteristics | ||||
| Comorbidity index | ||||
| Score 0 (reference category) | ||||
| Score >0 <1 | −0.021 | −0.056, 0.015 | 3.907 | 2.419, 5.396*** |
| Score ≥1§ | 0.045 | −0.038, 0.128 | 6.874 | 4.298, 9.450*** |
| Tumor stage | ||||
| Stage 0 (reference category) | ||||
| Stage 1 | −0.040 | −0.086, 0.006* | 0.043 | −1.745, 1.832 |
| Stage 2 | −0.039 | −0.092, 0.014 | −1.705 | −3.776, 0.366 |
| Stage unknown | −0.013 | −0.088, 0.061 | −2.060 | −4.901, 0.782 |
| Hormone receptor positive | 0.052 | 0.014, 0.090*** | 0.221 | −1.357, 1.800 |
| Sociodemographic | ||||
| Age | −0.004 | −0.006, −0.001*** | −0.058 | −0.149, 0.033 |
| Race | ||||
| White (reference category) | ||||
| Black | −0.034 | −0.072, 0.004* | −2.702 | −4.163, −1.240*** |
| Hispanic | −0.052 | −0.126, 0.022 | −1.127 | −5.110, 2.856 |
| Other | −0.118 | −0.225, −0.011** | −3.254 | −8.576, 2.069 |
| Multiple | −0.049 | −0.110, 0.011 | −1.534 | −4.224, 1.156 |
| Urban residence | −0.047 | −0.078, −0.016*** | −0.843 | −2.255, 0.569 |
| ABD classification | 0.027 | −0.028, 0.081 | 2.625 | 0.743, 4.507*** |
| BCCCP participation | 0.016 | −0.032, 0.064 | 2.371 | −0.205, 4.948* |
| Fully dual eligible | 0.029 | −0.012, 0.071 | −0.191 | −1.948, 1.565 |
| Year of diagnosis | ||||
| 2003 (reference category) | ||||
| 2004 | −0.011 | −0.048, 0.025 | −0.187 | −2.452, 2.078 |
| 2005 | −0.066 | −0.117, −0.015** | −0.318 | −2.620, 1.984 |
| 2006 | −0.028 | −0.071, 0.015 | −1.797 | −4.109, 0.515 |
| 2007 | −0.078 | −0.138, −0.017** | −1.765 | −4.289, 0.759 |
| Therapeutic characteristics | ||||
| Surgery type | ||||
| Both BCS and mastectomy (reference category) | ||||
| No surgery | −0.040 | −0.095, 0.014 | −0.823 | −3.206, 1.560 |
| Breast conserving surgery only | 0.027 | −0.024, 0.079 | 0.205 | −1.778, 2.188 |
| Mastectomy only | 0.045 | −0.006, 0.096* | −0.324 | −2.209, 1.561 |
| Chemotherapy | 0.067 | 0.022, 0.113*** | 4.689 | 3.132, 6.247*** |
| Radiation | 0.056 | 0.016, 0.095*** | 1.301 | −0.237, 2.839* |
| Observations | 612 | 581 | ||
Interaction term BCCCP × urban included.
***
P < 0.01,
**
P < 0.05,
*
P < 0.1.
†
Receipt of primary therapy within 15 mo of diagnosis.
‡
Physical exams received within 15 mo of completion of primary therapy.
§
Comorbidity categories were combined due to small cell sizes.
ABD indicates aged/blind/disabled; BCCCP, Breast and Cervical Cancer Control Program; BCS, breast conserving surgery; CI, confidence interval.